24.08.2013 Views

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Molecular and biochemical basis <strong>of</strong> disease<br />

is toxic to cells, not least due to its ability to catalyze, via the so-called<br />

Fenton reaction, the generation <strong>of</strong> aggressive free radicals . Therefore,<br />

every organism has mechanisms to control cellular uptake, distribution,<br />

detoxification and elimination <strong>of</strong> copper. Genetic defects in any <strong>of</strong><br />

these mechanisms as well as ecological abnormalities <strong>of</strong> copper balance<br />

result in neurodegenerative diseases . The systems that maintain<br />

copper homeostasis in mammalian brain are investigated poorly .<br />

This work was done using Wistar rats received 50 mg AgCl per kg <strong>of</strong><br />

body weight, daily, in four weeks . This model is characterized with copper-deficit<br />

in blood serum and normal copper metabolism in liver.<br />

Concentration <strong>of</strong> copper, zinc, iron, and silver was determined in cortex,<br />

cerebellum, hippocamp, hypothalamus, amygdaloid body, hypophysis<br />

by atomic-absorptive spectrometry . Copper-transporting proteins<br />

(CTR1, ATP7A/B, APP) and cuproenzymes (ceruloplasmin (Cp),<br />

GPI-Cp, SOD1, COX (Cox4i1)) mRNA levels were determined with<br />

semiquantitative RT-PCR . Protein amounts were valued by Westernblot<br />

. Furthermore Cp and SOD1 enzymatic activity were measured .<br />

It was shown that Ag-ions are selectively accumulated by hypophysis .<br />

Hypophysis accumulates Fe and Zn as well . Cu level is decreased<br />

in hypothalamus only . At the same time copper-transporting genes<br />

expression is going lower in all brain regions . The same is right for<br />

secretory cuproenzymes (Cp, GPI-Cp) . While level <strong>of</strong> intracellular cuproenzymes<br />

(SOD1, COX) doesn’t change. Effect <strong>of</strong> copper deficit in<br />

blood on copper metabolism in brain regions is discussed .<br />

P05.140<br />

Differential expression <strong>of</strong> neurokinin B and hemokinin 1 in<br />

human immune cells<br />

T. E. Klassert 1 , F. Pinto 2 , M. Hernández 1 , M. L. Candenas 2 , M. López 1 , M. C.<br />

Hernández 3 , J. Abreu 3 , T. A. Almeida 1 ;<br />

1 Instituto Universitario de Enfermedades Tropicales de Canarias, La Laguna,<br />

Spain, 2 Instituto de Investigaciones Químicas, CSIC, Sevilla, Spain, 3 Departamento<br />

de Neumología, Hospital Universitario de Canarias, La Laguna, Spain.<br />

Substance P (SP), neurokinin A (NKA), neurokinin B (NKB) and the<br />

recently identified hemokinin-1 (HK-1) are members <strong>of</strong> a family <strong>of</strong><br />

structurally related peptides known as tachykinins . They are mainly<br />

synthesized in the central and peripheral nervous system, but are also<br />

present in peripheral non-neuronal cells .<br />

In humans, substance P (SP) is the most extensively studied tachykinin<br />

and is present, along with the NK-1 receptor, in several inflammatory<br />

and immune cells . In these cells, SP has shown to play an important<br />

role in the regulation <strong>of</strong> immune functions and inflammatory responses.<br />

Up to day, there are no studies about the expression pattern <strong>of</strong> NKB<br />

and HK-1 in inflammatory and immune cells in humans. In the present<br />

study we have detected for the first time NKB and HK-1 mRNA in<br />

human lymphocytes, monocytes, neutrophils and eosinophils . In addition,<br />

and using immunocytochemistry with two different antibodies, we<br />

have detected the presence <strong>of</strong> NKB protein in all these cellular types .<br />

These findings reinforce the suggestion that tachykinins play a central<br />

role in the pathophysiology <strong>of</strong> the inflammatory process.<br />

P05.141<br />

Crosstalk between NF-kappaB and Wnt/beta-catenin pathways<br />

and anhidrotic ectodermal dysplasia<br />

C. Cluzeau1 , E. Bal1 , P. Guigue1 , N. Chassaing2 , S. Hadj-Rabia1,3 , C. Bodemer1,3<br />

, P. Calvas2 , M. Vincent2 , A. Munnich1 , A. Smahi1 ;<br />

1 2 INSERM U781, Paris, France, Service de genetique medicale, Toulouse,<br />

France, 3Service de dermatologie, Paris, France.<br />

Anhidrotic ectodermal dysplasia (EDA) is an ectodermal differentiation<br />

disorder characterized by sparse hair, abnormal or missing teeth and<br />

inability to sweat . X-linked EDA, caused by mutations in EDA gene<br />

encoding ectodysplasine, a member <strong>of</strong> the TNF family, is the most<br />

frequent form . The autosomal dominant and recessive EDA forms,<br />

clinically identical to X-linked forms, may result from mutations in two<br />

loci : ED3, encoding Edar, ectodysplasin receptor and ED2, encoding<br />

Edaradd, Edar adapter molecule necessary in signal transduction .<br />

Edar is activated by ectodysplasine and uses Edaradd as an adapter<br />

to activate NF-kappaB signaling pathway . Wnt/beta-catenin pathway<br />

plays a central role during embryonic development and is widely involved<br />

in carcinogenesis . This pathway has been recently involved in<br />

skin appendages formation . A crosstalk between NF-kappaB and Wnt/<br />

beta-catenin pathway was described .<br />

We confirmed by transactivation experiments that Edar receptor inhib-<br />

its Wnt/beta-catenin pathway . We then studied the effects <strong>of</strong> seven recessive<br />

and dominant mutations identified in Edar gene on both pathways<br />

. Dominant mutations totally impaired NF-kappaB activation and<br />

Wnt/beta-catenin downregulation, while recessive ones only disrupted<br />

the Edar effect on both pathways .<br />

We first demonstrated that Wnt/beta-catenin inhibition by Edar is dependent<br />

<strong>of</strong> NF-kappaB activation using a dominant negative form <strong>of</strong><br />

IkappaBalpha inhibitor . We then proved by Western Blot analysis and<br />

immun<strong>of</strong>luorescence that beta-catenin was neither degraded nor delocalized<br />

after NF-kappaB activation by Edar . Furthermore, beta-catenin/<br />

TCF4 interaction, necessary for Wnt/beta-catenin transcriptional activity,<br />

was not disrupted upon Edar transfection and NF-kappaB subunits<br />

p65 and p50 did not interact with beta-catenin in these conditions .<br />

P05.142<br />

Nijmegen breakage syndrome in Ukraine: molecular and<br />

cytogenetic studies<br />

H. Makukh 1 , L. Chorna 1 , B. Tretjak 1 , H. Bezkorovaina 1 , G. Akopian 1 , L.<br />

Kostyuchenko 2 , N. Markevush 1 ;<br />

1 State institution “Institute <strong>of</strong> Hereditary Pathology <strong>of</strong> Academy <strong>of</strong> Medical<br />

Science <strong>of</strong> Ukraine”, Lviv, Ukraine, 2 Lviv Specialized Children’s Clinic, Lviv,<br />

Ukraine.<br />

Nijmegen breakage syndrome (NBS) is considered as a rare autosomal<br />

recessive disease, but its actual prevalence is not known . 95% <strong>of</strong><br />

NBS patients are <strong>of</strong> Slavic descent and 90% <strong>of</strong> them are homozygous<br />

for a founder 657del5 mutation in the NBN gene . In 1999-2007 a total<br />

<strong>of</strong> 26 patients were diagnosed with NBS in Ukraine, 23 <strong>of</strong> which residing<br />

in Western Ukraine region .<br />

We performed 208 molecular-genetic tests <strong>of</strong> the 657del5 mutation<br />

NBN gene among the group <strong>of</strong> patients with microcephaly and identified<br />

24 homozygous for 657del5 mutation. It had been performed 4<br />

prenatal NBS diagnostics and we identified two homozygous and two<br />

heterozygous fetus for 657del5 mutation .<br />

We detected the specific chromosomal rearrangements in lymphocyte<br />

cell culture <strong>of</strong> NBS patients: 3% <strong>of</strong> the cases - inv(7)(p13q35),<br />

2% - t(7;14)(q35;q11), t(7;7)(p13;q35), del(7)(q35), del(14)(q11), 1%<br />

- t(7;14)(p13;q11) . An additional marker chromosome (10% <strong>of</strong> the<br />

cells with translocations) and nonspecific chromosomal abnormalities<br />

(mostly 1, 3, 8 and 9) were found too .<br />

As the expression <strong>of</strong> IL-10 may influence the development and progression<br />

<strong>of</strong> tumor we studied the distribution <strong>of</strong> three biallelic polymorphisms<br />

at positions -1082, -819 and -592 <strong>of</strong> the promoter region<br />

<strong>of</strong> IL-10 gene . The haplotype IL-10 GCC (37%) was found to be the<br />

most frequent .<br />

P05.143<br />

Genetic heterogeneity <strong>of</strong> nonbullous congenital ichthyosiform<br />

erythroderma<br />

N. N. Vasserman, V. A. Galkina, O. N. Makienko, E. G. Okuneva, G. E. Rudenskaya;<br />

Research Center for Medical <strong>Genetics</strong>, Moscow, Russian Federation.<br />

Nonbullous congenital ichthyosiform erythroderma (NCIE, MIM<br />

242100) is a severe autosomal recessive disorder . About 90% <strong>of</strong> affected<br />

newborns present as “collodion babies” . Many patients die in<br />

neonatal period from disorders <strong>of</strong> thermoregulation and infections . In<br />

survivors, though, skin lesions improve with age, few patients have<br />

neurological symptoms, while others live with little or no problems .<br />

NCIE is genetically heterogeneous . To date, TGM1, ALOX12B, AL-<br />

OXE3, ABCA12, CYP4F22 responsible genes were identified, and<br />

mutations in the latter two are rare .<br />

We performed DNA diagnostics in five NCIE families <strong>of</strong> which mutations<br />

were found in four: one <strong>of</strong> Azerbaijan and three <strong>of</strong> Russian ethnicity<br />

. (1) In a consanguineous Azerbaijan family two affected children<br />

died within first days, their DNA samples were unavailable. In parents<br />

a novel TCM1 mutation Arg142His was detected . On prenatal DNA<br />

diagnostics the mutation was not found in the fetus, thus the prognosis<br />

was favourable . (2) The couple abandoned the affected baby and<br />

had no information about him . Parents were found heterozygous for<br />

novel ALOX12B mutations: Ala597Glu and Tyr97Stop . Prenatal DNA<br />

diagnostics revealed unfavourable prognosis since the fetus inherited<br />

mutations from both parents . (3) In a family with a deceased newborn<br />

child a novel ALOX12 mutation Asn594His was identified in the<br />

father and a previously recorded Tyr521Cys in the mother . (4) In a<br />

0

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!